📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: e-Zyvec

1.1 - Company Overview

e-Zyvec Logo

e-Zyvec

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of molecular biology solutions for academic and industrial scientists conducting research with genetic engineering applications; a biotechnology company specializing in genetic engineering, founded in 2016 and headquartered in Loos, France.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to e-Zyvec

OXGENE Logo

OXGENE

HQ: United Kingdom Website
  • Description: Provider of versatile cloning plasmids for research, custom cloning and DNA synthesis, and IP-free products. Offers TESSA technology for scalable, cost-effective AAV manufacturing, high-titre transient rAAV production, cell and gene therapy acceleration services (including CAR-T), cell line development and engineering, and LentiVEX plasmids and cell lines for lentiviral vector production.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OXGENE company profile →
DNAfit Logo

DNAfit

HQ: United Kingdom Website
  • Description: Provider of at-home DNA testing and genetic insights for health, fitness, and nutrition. Offerings include CircleDNA Premium (500+ reports via saliva swab), genetic carrier screening, disease and cancer risk overviews, diet and fitness reports, skin predisposition insights, and success trait summaries to help personalize exercise, nutrition, and skincare choices.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNAfit company profile →
Oxford BioDynamics Logo

Oxford BioDynamics

HQ: United Kingdom Website
  • Description: Provider of epigenetic biomarker research and development solutions for pharma and biotech via its proprietary EpiSwitch platform, offering blood tests such as EpiSwitch PSE for prostate cancer risk, CiRT for checkpoint inhibitor therapy success, and CST for COVID-19 severity, plus genome mapping tools including EpiSwitch Platform, Explorer Array Kit, and EpiSwitch Portal for diagnostics, prognostics, and health outcome insights.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxford BioDynamics company profile →
GenSight Biologics Logo

GenSight Biologics

HQ: France Website
  • Description: Provider of gene therapy-based treatments for retinal degenerative diseases. Develops candidates such as GS010 (lenadogene nolparvovec) for Leber Hereditary Optic Neuropathy (LHON) and GS030, an optogenetics-based therapy in Phase I/II trials, leveraging mitochondrial targeting sequence (MTS) technology and optogenetics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GenSight Biologics company profile →
Scribe Therapeutics Logo

Scribe Therapeutics

HQ: United States Website
  • Description: Provider of CRISPR-based therapeutic platforms and medicines, including X-Editing (XE) technologies for high-activity, specific, deliverable gene editing; CRISPR by Design optimization; ELXR CasX-based epigenetic repressors; in vivo CRISPR genetic medicines (e.g., for sickle cell) with non-viral delivery; and ex vivo natural killer (NK) cell therapies for cancer in collaboration with Sanofi.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Scribe Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for e-Zyvec

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to e-Zyvec

2.2 - Growth funds investing in similar companies to e-Zyvec

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for e-Zyvec

4.2 - Public trading comparable groups for e-Zyvec

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to e-Zyvec

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About e-Zyvec

What does e-Zyvec do?

e-Zyvec is a provider of molecular biology solutions for academic and industrial scientists conducting research with genetic engineering applications; a biotechnology company specializing in genetic engineering, founded in 2016 and headquartered in Loos, France.

Who are e-Zyvec's competitors?

e-Zyvec's competitors and similar companies include OXGENE, DNAfit, Oxford BioDynamics, GenSight Biologics, and Scribe Therapeutics.

Where is e-Zyvec headquartered?

e-Zyvec is headquartered in France.

How many employees does e-Zyvec have?

e-Zyvec has 1,000 employees 🔒.

When was e-Zyvec founded?

e-Zyvec was founded in 2010 🔒.

What sector and industry vertical is e-Zyvec in?

e-Zyvec is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for e-Zyvec

Who are the top strategic acquirers in e-Zyvec's sector and industry

Top strategic M&A buyers and acquirers in e-Zyvec's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for e-Zyvec?

Top strategic M&A buyers groups and sectors for e-Zyvec include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in e-Zyvec's sector and industry vertical

Which are the top PE firms investing in e-Zyvec's sector and industry vertical?

Top PE firms investing in e-Zyvec's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in e-Zyvec's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in e-Zyvec's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in e-Zyvec's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to e-Zyvec include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in e-Zyvec's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for e-Zyvec?

The key public trading comparables and valuation benchmarks for e-Zyvec include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for e-Zyvec for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for e-Zyvec with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in e-Zyvec's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for e-Zyvec with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in e-Zyvec's' sector and industry vertical?

Access recent funding rounds and capital raises in e-Zyvec's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for e-Zyvec